Results 121 to 130 of about 1,805,472 (279)

Direct non-medical costs and influencing factors of patients with non-small cell lung cancer treated with targeted therapy: A cross-sectional study in Vietnam

open access: yesVietnam Journal of Science, Technology and Engineering
To estimate the direct non-medical costs and related factors for patients with nonsmall cell lung cancer (NSCLC) with estimated glomerular filtration rate (EGFR) mutations who received first-line targeted therapy, a cross-sectional study was conducted ...
Van Chinh Nguyen   +5 more
doaj  

The economic burden of musculoskeletal disease in Korea: A cross sectional study

open access: yesBMC Musculoskeletal Disorders, 2011
Background Musculoskeletal diseases are becoming increasingly important due to population aging. However, studies on the economic burden of musculoskeletal disease in Korea are scarce.
Kim Eun-Jung   +4 more
doaj   +1 more source

The Burden of Obesity in Saudi Arabia: A Real-World Cost-of-Illness Study

open access: yesClinicoEconomics and Outcomes Research
Background The rising prevalence of obesity in the Kingdom of Saudi Arabia (KSA) poses a significant public health challenge. Estimates of the economic cost of obesity are crucial for prioritizing healthcare interventions, guiding policy choices, and ...
M. Nagi   +10 more
semanticscholar   +1 more source

Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: an Italian cost impact study

open access: yesAIDS Research and Therapy, 2017
BackgroundLate presentation (LP) at the time of HIV diagnosis is defined as presentation with AIDS whatever the CD4 cell count or with CD4
G. Guaraldi   +11 more
semanticscholar   +1 more source

One size does not fit all: An in vitro evaluation of the effects of bezafibrate and medroxyprogesterone acetate on human SH‐SY5Y and U‐87 MG cancer cells

open access: yesFEBS Open Bio, EarlyView.
Drugs previously repurposed to target blood cancers reduced neuroblastoma and glioblastoma cell growth and viability. However, their levels of anticancer activity were different and their clinical application may be problematic due to side effects at effective doses.
Abhishek Kharawatkar   +4 more
wiley   +1 more source

Preliminary investigation on the economic cost of mitochondrial disease in Chinese children

open access: yesOrphanet Journal of Rare Diseases
Background The prevalence of mitochondrial diseases is increasing, leading to a significant economic burden on families and society. However, nationwide cost data on their effects on China’s economy remain limited.
Chaolong Xu   +10 more
doaj   +1 more source

Re‐Awakening Public Attention to the Silent Pandemic of Cancer Among Older Adults in Low‐ and Middle‐Income Countries

open access: yesAging and Cancer, EarlyView.
ABSTRACT As global populations age, cancer is increasingly becoming a leading cause of morbidity and mortality among older adults, particularly in low‐ and middle‐income countries (LMICs). Despite accounting for the majority of new cancer cases and deaths, older individuals remain underrepresented in cancer research, clinical guidelines, and health ...
Ibrahim Bidemi Abdullateef   +2 more
wiley   +1 more source

MITK-ModelFit: A generic open-source framework for model fits and their exploration in medical imaging -- design, implementation and application on the example of DCE-MRI

open access: yes, 2019
Many medical imaging techniques utilize fitting approaches for quantitative parameter estimation and analysis. Common examples are pharmacokinetic modeling in DCE MRI/CT, ADC calculations and IVIM modeling in diffusion-weighted MRI and Z-spectra analysis
Abdollahi, Amir   +6 more
core   +1 more source

Economic burden of psoriasis in Southern Iran in 2022

open access: yesArchives of Public Health
Introduction Psoriasis is a common, chronic, and non-contagious skin disease that has no known cause or treatment. Various medical costs for skin disorders, including psoriasis, can be expensive and lifelong.
Ramin Ravangard   +3 more
doaj   +1 more source

Aging Is a Key Driver for Adult Acute Myeloid Leukemia

open access: yesAging and Cancer, EarlyView.
Acute myeloid leukemia (AML) is a classical age‐related hematologic malignancy, and a key driver of AML is aging, which profoundly regulates intrinsic factors such as genomic instability, epigenetic reprogramming, and metabolic dysregulation, and alters bone marrow microenvironment.
Rong Yin, Haojian Zhang
wiley   +1 more source

Home - About - Disclaimer - Privacy